Protagonist Therapeutics, Inc. · NASDAQ:PTGX

Dapice Joshua J. reported a 9.99% stake in Protagonist Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 10, 2025

Dapice Joshua J. reported a 9.99% stake in Protagonist Therapeutics, Inc., 5,956,488 shares, as a passive investor on Dec 31, 2024. Filed Feb 10, 2025 (Schedule 13G/A).

Stake
9.99%
Shares
5,956,488
Intent
Passive
What changed
Stake changed
Filed together
30 holders

The filing in full

HolderStakeShares
Farallon Capital Partners, L.P.0.50%297,773
Farallon Capital Institutional Partners, L.P.0.50%304,745
Farallon Capital Institutional Partners II, L.P.0.20%96,908
Farallon Capital Institutional Partners III, L.P.0.10%40,829
Four Crossings Institutional Partners V, L.P.0.10%55,638
Farallon Capital Offshore Investors II, L.P.1.00%591,086
Farallon Capital (AM) Investors, L.P.0.10%38,527
Farallon Capital F5 Master I, L.P.0.20%130,226
Farallon Healthcare Partners Master, L.P.7.40%4,400,756
Farallon Partners, L.L.C.9.80%5,826,262
Farallon Institutional (GP) V, L.L.C.0.10%55,638
Farallon F5 (GP), L.L.C.0.20%130,226
Farallon Healthcare Partners (GP), L.L.C.7.40%4,400,756
Dapice Joshua J.9.99%5,956,488
Dreyfuss, Philip D.9.99%5,956,488
Dunn Hannah E.9.99%5,956,488
Fried, Richard B9.99%5,956,488
Gehani, Varun N.9.99%5,956,488
Giauque, Nicolas9.99%5,956,488
Kim, David T.9.99%5,956,488
Linn, Michael G.9.99%5,956,488
Luo Patrick (Cheng)9.99%5,956,488
Patel, Rajiv A.9.99%5,956,488
Roberts, Jr., Thomas G.9.99%5,956,488
Saito Edric C.9.99%5,956,488
Seybold, William9.99%5,956,488
Short Daniel S.9.99%5,956,488
Spokes, Andrew J. M.9.99%5,956,488
Warren, John R.9.99%5,956,488
Wehrly, Mark C.9.99%5,956,488

Source

View original at SEC

Related